OrphanDrug
OrphanDrug
Pharma Knowledge Base

hyperinsulinism due to INSR deficiency

ORPHA: 263458

Contents

  1. 1. Available Treatments
  2. 2. Clinical Presentation
  3. 3. Classification & Codes

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with hyperinsulinism due to INSR deficiency, sourced from HPO and Orphanet clinical annotations.

Hyperinsulinemic hypoglycemiaHypoglycemiaRecurrent hypoglycemiaFasting hyperinsulinemiaAbnormal circulating C-peptide concentrationSeizureFatigueInsulin resistanceComa

Classification & Codes

Orphanet Code

ORPHA:263458
hyperinsulinism due to INSR deficiency
OrphanetORPHA:263458
Treatments0 drug(s)
Symptoms on record9 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
hyperinsulinism due to INSR deficiency | OrphanDrug